Table 1.
Demographics and sample characteristics
| Full sample (n = 69) | Less than 2112 days (n = 35) | More than 2112 days (n = 34) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| M | S.D. | M | S.D. | M | S.D. | ||||
| Age | 39.72 | 38.00 | 11.13 | 34.11 | 33.00 | 6.91 | 45.50 | 43.50 | 11.77 |
| DUNDRUM-1 triage security (0–4) | 3.03 | 3.00 | 0.47 | 2.95 | 3.00 | 0.55 | 3.07 | 3.06 | 0.38 |
| Length of stay at baseline (years) | 7.94 | 5.00 | 8.71 | 2.54 | 3.00 | 1.96 | 13.50 | 11.00 | 9.46 |
| Length of follow-up (years) | 3.42 | 4.00 | 1.32 | 3.03 | 4.00 | 1.62 | 3.82 | 4.00 | 0.76 |
| MCCB composite (t-score) | 21.09 | 21.00 | 14.21 | 19.68 | 16.00 | 14.34 | 22.53 | 23.50 | 14.14 |
| PANSS total score | 64.27 | 60.00 | 21.80 | 67.74 | 63.00 | 25.79 | 60.71 | 58.50 | 16.36 |
| PANSS positive | 14.31 | 12.00 | 7.98 | 15.41 | 13.00 | 9.38 | 13.22 | 11.50 | 6.23 |
| PANSS negative | 19.08 | 18.50 | 7.86 | 18.69 | 18.00 | 8.25 | 19.47 | 19.00 | 7.56 |
| CPZeq (mg/day) | 529.57 | 467.00 | 341.92 | 526.66 | 500.00 | 284.27 | 532.58 | 458.50 | 397.03 |
Note: mean, SD standard deviation, M median, MCCB MATRICS consensus cognitive battery, PANSS Positive and Negative Syndrome Scale, CPZeq Chlorpromazine equivalent